Sugden, M
Recent developments: April 2026, The FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, potentially limiting large-scale compounding activities
Retinoids, AHAs, BHAs, and benzoyl peroxide all increase transepidermal water loss
For the majority of patients (75 to 85%), meaningful side effect resolution occurs by week 3 to 4 at each dose, and most side effects are nearly gone by month 3 to 4 of total treatment
Blood pressure-specific Vitamin D influences the production of renin, an enzyme that regulates blood pressure
May your GH pulses stay strong, your pituitary stay responsive, and your protocols stay consistent.